138-55-6
中文名稱
苦番紅花素
英文名稱
Picrocrocin
CAS
138-55-6
分子式
C16H26O7
分子量
330.37
MOL 文件
138-55-6.mol
更新日期
2026/07/07 17:09:44
138-55-6 結構式
基本信息
中文別名
苦番花素苦藏花素
藏紅花苦甙
苦番紅花素
苦番紅花素
英文別名
PicrocrocinSafranbitter
Picrocrocine
Saffron-bitter
Picrocrocin USP/EP/BP
Picrocrocin Safranbitter
(R)-4-(β-D-Glucopyranosyloxy)-2,6,6-trimethyl-1-cyclohexene-1-carbaldehyde
(R)-4-(β-D-glucopyranosiloxy)-2,6,6-trimethyl-1-cyclohexene-1-carbaldehyde
1-Cyclohexene-1-carboxaldehyde,4-(b-D-glucopyranosyloxy)-2,6,6-triMethyl-,(4R)-
1-Cyclohexene-1-carboxaldehyde, 4-(β-D-glucopyranosyloxy)-2,6,6-trimethyl-, (4R)-
所屬類別
生物化工：中草藥成分物理化學性質
熔點196℃ (ethyl acetate )
比旋光度D20 -58° (c = 0.6)
沸點520.4±50.0 °C(Predicted)
密度1.31±0.1 g/cm3 (20 ºC 760 Torr)
儲存條件4°C, protect from light
溶解度Acetonitrile: Slightly Soluble
Methanol: Soluble
Water: Slightly Soluble
Methanol: Soluble
Water: Slightly Soluble
酸度系數(shù)(pKa)12.91±0.70(Predicted)
形態(tài)Solid
顏色White to off-white
InChIInChI=1/C16H26O7/c1-8-4-9(5-16(2,3)10(8)6-17)22-15-14(21)13(20)12(19)11(7-18)23-15/h6,9,11-15,18-21H,4-5,7H2,1-3H3/t9-,11-,12-,13+,14-,15-/s3
InChIKeyWMHJCSAICLADIN-LZYGGLMUNA-N
SMILES[C@@H]1(O[C@H]2CC(C)(C)C(C=O)=C(C)C2)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |&1:0,2,14,17,19,21,r|
LogP-0.240 (est)
苦番紅花素價格(試劑級)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-N4114R | 苦番紅花素 Picrocrocin (Standard) | 138-55-6 | 1 mg | 2500元 |
| 2026/06/05 | HY-N4114R | 苦番紅花素 Picrocrocin (Standard) | 138-55-6 | 5 mg | 5500元 |
| 2026/06/05 | HY-N4114R | 苦番紅花素 Picrocrocin (Standard) | 138-55-6 | 10 mg | 8800元 |
常見問題列表
生物活性
Picrocrocin，一種發(fā)現(xiàn)于椰菜花中的類胡蘿卜素。Picrocrocin 具有抗癌作用。Picrocrocin 對 SKMEL-2 人惡性黑色素瘤細胞具有生長抑制作用。體外研究
Picrocrocin exerted growth inhibitory effects on the SK-MEL-2 melanoma cells. The IC 50 of picrocrocin against the SK-MEL-2 cells was 20 μM at 24-h incubation. The antiproliferative activity of picrocrocin was due to apoptosis and cell cycle arrest. In addition, picrocrocin enhanced the ROS levels and decreased the MMP levels of SK-MEL-2 cells. Finally, picrocrocin inhibited the JAK/STAT5 signalling pathway in the SK-MEL-2 melanoma cells.